|
US approves Pharmaxis asthma test
Sydney Morning Herald Pharmaxis Ltd, which develops treatments for respiratory and autoimmune diseases, has won regulatory approval to sell its asthma test kit, Aridol, … Pharmaxis (PXS) $2.40: Tim Boreham |
View full post on asthma – Google News